[go: up one dir, main page]

CY1108494T1 - Παραγωγα α-αμινοαμιδης χρησιμα στη θεραπεια του συνδρομου αεικινητων ποδιων και στη θεραπεια εθιστικων διαταραχων - Google Patents

Παραγωγα α-αμινοαμιδης χρησιμα στη θεραπεια του συνδρομου αεικινητων ποδιων και στη θεραπεια εθιστικων διαταραχων

Info

Publication number
CY1108494T1
CY1108494T1 CY20081101279T CY081101279T CY1108494T1 CY 1108494 T1 CY1108494 T1 CY 1108494T1 CY 20081101279 T CY20081101279 T CY 20081101279T CY 081101279 T CY081101279 T CY 081101279T CY 1108494 T1 CY1108494 T1 CY 1108494T1
Authority
CY
Cyprus
Prior art keywords
treatment
addictive disorders
aminoamidis
immune
legs syndrome
Prior art date
Application number
CY20081101279T
Other languages
English (en)
Inventor
Claudia Besana
Elena Barbanti
Emanuela Izzo
Florian Thaler
Ruggero Fariello
Patricia Salvati
Luca Benatti
Original Assignee
Newron Pharmaceuticals S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharmaceuticals S.P.A. filed Critical Newron Pharmaceuticals S.P.A.
Publication of CY1108494T1 publication Critical patent/CY1108494T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση σχετίζεται με τη χρήση κάποιων παραγώγων άλφα-αμινοαμίδης στη θεραπεία του RLS (Σύνδρομο αεικίνητων ποδιών) και στη θεραπεία εθιστικών διαταραχών. Τα σκευάσματα της εφεύρεσης αυτής είναι ικανά να μειώσουν ή ακόμα και να σταματήσουν τα συμπτώματα του RLS και των εθιστικών διαταραχών σε ικανοποιητικό βαθμό χωρίς παρενέργειες.
CY20081101279T 2004-04-22 2008-11-10 Παραγωγα α-αμινοαμιδης χρησιμα στη θεραπεια του συνδρομου αεικινητων ποδιων και στη θεραπεια εθιστικων διαταραχων CY1108494T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04009532A EP1588704A1 (en) 2004-04-22 2004-04-22 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
EP05736365A EP1737438B1 (en) 2004-04-22 2005-04-19 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome

Publications (1)

Publication Number Publication Date
CY1108494T1 true CY1108494T1 (el) 2014-04-09

Family

ID=34924693

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20081101279T CY1108494T1 (el) 2004-04-22 2008-11-10 Παραγωγα α-αμινοαμιδης χρησιμα στη θεραπεια του συνδρομου αεικινητων ποδιων και στη θεραπεια εθιστικων διαταραχων
CY20111100255T CY1111656T1 (el) 2004-04-22 2011-03-04 Παραγωγα αλφα-αμινοαμιδιου χρησιμα εις την θεραπευτικη αγωγη εθιστικων παθησεων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20111100255T CY1111656T1 (el) 2004-04-22 2011-03-04 Παραγωγα αλφα-αμινοαμιδιου χρησιμα εις την θεραπευτικη αγωγη εθιστικων παθησεων

Country Status (25)

Country Link
US (2) US8445513B2 (el)
EP (3) EP1588704A1 (el)
JP (1) JP5020069B2 (el)
KR (2) KR101195819B1 (el)
CN (1) CN1942179B (el)
AT (2) ATE405256T1 (el)
AU (1) AU2005235428B2 (el)
BR (2) BRPI0509976B8 (el)
CA (1) CA2563674C (el)
CY (2) CY1108494T1 (el)
DE (2) DE602005025941D1 (el)
DK (2) DK1900362T3 (el)
ES (2) ES2357559T3 (el)
HR (2) HRP20080593T3 (el)
IL (1) IL178732A (el)
ME (2) ME01219B (el)
MX (1) MXPA06012163A (el)
NO (2) NO337900B1 (el)
NZ (1) NZ550664A (el)
PL (2) PL1737438T3 (el)
PT (2) PT1900362E (el)
RS (2) RS51791B (el)
RU (1) RU2403030C2 (el)
SI (2) SI1737438T1 (el)
WO (1) WO2005102300A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
ATE317280T1 (de) * 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
PT1658062E (pt) * 2003-08-25 2010-03-31 Newron Pharm Spa Derivados de alfa-amino amida úteis como agentes antiinflamatórios
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
JP2008519811A (ja) * 2004-11-10 2008-06-12 オリオン コーポレーション 下肢静止不能症候群の治療
NZ567540A (en) * 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
MX2008012781A (es) * 2006-04-03 2008-10-14 Teva Pharma Uso de rasagilina para el tratamiento de sindrome de piernas inquietas.
EP1870097A1 (en) 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EA025326B1 (ru) * 2006-06-19 2016-12-30 Ньюрон Фармасьютикалс С.П.А. Применение сафинамида и ралфинамида высокой степени чистоты для лечения заболеваний и болезненных состояний в условиях, не препятствующих активности цитохромов системы cyp450 и не проявляющих блокирующих свойств в отношении herg канала
GB0706630D0 (en) * 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
AU2008261325B2 (en) 2007-06-15 2012-12-06 Newron Pharmaceuticals S.P.A. Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
CN101896456B (zh) 2007-12-11 2014-10-22 纽朗制药有限公司 具有高纯度的2-[4-(3-或2-氟苄氧基)苄氨基]丙酰胺类的生产方法
EA019529B1 (ru) * 2007-12-19 2014-04-30 Ньюрон Фармасьютикалс С.П.А. Альфа-аминоамидные производные, применяемые в лечении психиатрических расстройств
EP2314569A1 (en) 2009-10-22 2011-04-27 Merck Patent GmbH Novel polymorphic forms of (S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof
KR101851118B1 (ko) 2010-04-27 2018-04-23 뉴론 파마슈티칼즈 에스. 피. 에이. 랄핀아미드 메탄설포네이트 염들 또는 이들의 ｒ―에난티오머들의 제조 방법
US11278651B2 (en) 2018-10-17 2022-03-22 Gambro Lundia Ab Membrane and device for treating restless leg syndrome
CN114667963B (zh) * 2020-12-24 2024-04-26 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物药物成瘾性评估的装置

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4935429A (en) * 1985-10-25 1990-06-19 Dackis Charles A Method of treating psychostimulant addiction
EP0331620B1 (de) * 1988-03-01 1993-08-11 Birkmayer, Walther, Prof. Dr. Mittel zur Behandlung des Parkinson-Syndroms
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5221536A (en) * 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
EP0520325A1 (de) * 1991-06-28 1992-12-30 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Monoaminoxidase-B-Hemmern zur Verhütung und Behandlung von Entzugserscheinungen nach Alkohol- und Drogenmissbrauch
GB9306886D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
IL111240A (en) * 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
US6258827B1 (en) * 1995-05-26 2001-07-10 Pfizer Inc. Combinations for the treatment of parkinsonism containing selective NMDA antagonists
AU3155995A (en) 1995-06-17 1997-01-15 Gunter Baumann Disc-shaped member
GB9515411D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa N-(4-substituted-benzyl)-2-aminolactam derivatives
GB9515412D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
GB9727521D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Substituted 2-benzylamino-2-phenyl-acetamide compounds
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6348074B2 (en) 1998-01-12 2002-02-19 Saga Fuel Systems, Inc. Composition as an additive to create clear stable solutions and microemulsions with a combustible liquid fuel to improve combustion
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
AU1359801A (en) * 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
AU2080201A (en) 1999-12-10 2001-06-18 University Of Cincinnati, The Treatment of addiction disorders
US20020019421A1 (en) * 2000-07-05 2002-02-14 Roni Biberman Compositions and therapy for substance addiction
CA2450315A1 (en) * 2001-06-13 2002-12-19 The Regents Of The University Of Michigan Dopamine receptor ligands and therapeutic methods based thereon
SI1511718T1 (sl) * 2002-05-29 2009-08-31 Hoffmann La Roche Derivati n-acilaminobenzena kot selektivni inhibitorji monoaminske oksidaze b
PL203763B1 (pl) 2002-06-24 2009-11-30 Rockwool Int Sposób i urządzenie do wytwarzania wełny mineralnej
US6900354B2 (en) * 2002-07-15 2005-05-31 Hoffman-La Roche Inc. 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
JP2005060370A (ja) * 2003-07-25 2005-03-10 Kyowa Hakko Kogyo Co Ltd 医薬組成物
EP1524267A1 (en) 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Substituted benzylaminoalkylene heterocycles
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders

Also Published As

Publication number Publication date
KR20120028399A (ko) 2012-03-22
RU2403030C2 (ru) 2010-11-10
EP1737438B1 (en) 2008-08-20
RS51791B (sr) 2011-12-31
WO2005102300A1 (en) 2005-11-03
DE602005025941D1 (de) 2011-02-24
PL1737438T3 (pl) 2009-01-30
NO20150971L (no) 2006-11-22
NO338870B1 (no) 2016-10-31
HRP20080593T3 (en) 2008-12-31
CA2563674A1 (en) 2005-11-03
US8445513B2 (en) 2013-05-21
ES2313330T3 (es) 2009-03-01
PT1900362E (pt) 2011-03-09
DK1737438T3 (da) 2008-12-08
HRP20110230T1 (hr) 2011-04-30
ES2357559T3 (es) 2011-04-27
US20070203182A1 (en) 2007-08-30
NZ550664A (en) 2010-08-27
BR122020004541B1 (pt) 2021-11-09
JP5020069B2 (ja) 2012-09-05
BRPI0509976B1 (pt) 2020-10-06
RS50667B (sr) 2010-06-30
ME02324B (me) 2016-06-20
IL178732A (en) 2013-01-31
SI1737438T1 (sl) 2008-12-31
KR101195819B1 (ko) 2012-11-05
ATE405256T1 (de) 2008-09-15
US8697738B2 (en) 2014-04-15
NO20064732L (no) 2006-11-22
ME01219B (me) 2013-06-20
NO337900B1 (no) 2016-07-04
DK1900362T3 (da) 2011-05-09
EP1900362A2 (en) 2008-03-19
CY1111656T1 (el) 2015-10-07
CN1942179B (zh) 2010-08-11
KR20070042914A (ko) 2007-04-24
HK1099216A1 (en) 2007-08-10
RU2006137079A (ru) 2008-04-27
PL1900362T3 (pl) 2011-06-30
BRPI0509976B8 (pt) 2021-05-25
MXPA06012163A (es) 2007-01-17
JP2007533691A (ja) 2007-11-22
AU2005235428B2 (en) 2010-03-18
US20130217747A1 (en) 2013-08-22
EP1588704A1 (en) 2005-10-26
EP1900362A3 (en) 2009-04-01
KR101238377B1 (ko) 2013-03-04
EP1900362B1 (en) 2011-01-12
CA2563674C (en) 2012-12-18
SI1900362T1 (sl) 2011-03-31
PT1737438E (pt) 2008-12-22
ATE494890T1 (de) 2011-01-15
IL178732A0 (en) 2007-05-15
EP1737438A1 (en) 2007-01-03
BRPI0509976A (pt) 2007-10-16
CN1942179A (zh) 2007-04-04
AU2005235428A1 (en) 2005-11-03
DE602005009162D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
CY1108494T1 (el) Παραγωγα α-αμινοαμιδης χρησιμα στη θεραπεια του συνδρομου αεικινητων ποδιων και στη θεραπεια εθιστικων διαταραχων
AR031152A1 (es) Tratamientos nuevos para el sindrome de piernas inquietas
CY1111757T1 (el) Παραγωγα ξανθινης ως εκλεκτικοι αναστολεις ημ74α
CY1116571T1 (el) Ενωσεις φωσφορικου αμινοαλκυλο γλυκοζαμinιδιου και χρηση αυτων
CY1105586T1 (el) Ιμιδαζοκουινολινες υποκατεστημενες με θειοαιθερα
CY1105286T1 (el) Ω-καρβοξυαρυλυποκατεστημενες διφαινυλουριες σαν αναστολεις της raf κινασης
CY1109677T1 (el) Παραγωγα κινολινης και χρηση αυτων ως μυκοβακτηριακων αναστολεων
CY1111767T1 (el) Υδρογονωμενα παραγωγα βενζο[c]θειοφαινιου ως ανοσορρυθμιστες
CY1116295T1 (el) Αναστολεις της κινασης τυροσινης toy bruton
CY1114238T1 (el) 2,4 – δι (φαινυλαμινο) - πυριμιδινες χρησιμες στην αντιμετωπιση των νεοπλασματικων παθησεων, των φλεγμονωδων διαταραχων και των διαταραχων του ανοσοποιητικου συστηματος
CY1108077T1 (el) Αρυλο-υποκατεστημενες πολυκυκλικες αμινες, μεθοδος για την παρασκευη τους και η χρηση τους ως φαρμακων
CY1115745T1 (el) Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου
IS2873B (is) 2,4-pýrímídíndíamín gagnleg við meðhöndlun á æxlissjúkdómum, bólgu- og ónæmiskerfiskvillum
CY1107440T1 (el) Ενωσεις αρυλουριας εν συνδυασμω με αλλα κυτταροστατικα ή κυτταροτοξικα μεσα για τη θεραπεια ανθρωπινων καρκινων
CY1112682T1 (el) Ενεργες παραλλαγες της πρωτεϊνης προσδεσης il-18 και ιατρικες χρησεις αυτων
DK1542729T3 (da) Stabilt immunogent produkt omfattende antigene heterokomplekser
CY1113404T1 (el) Μεθοδος αντιμετωπισης ή προληψης της πολυ- οργανικης ανεπαρκειας
DK1776340T3 (da) N - (1 H-indolyl) -1 H - indol - 2 - carboxamid-derivater, fremstilling og terapeutisk anvendelse heraf
BR0313665A (pt) Utilização de bupropion para o tratamento da sìndrome das pernas inquietas
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
ITMI20020662A0 (it) Gambe pieghevoli per piani di appoggio
TR200202346U (tr) Mobilyalar için ayarlanabilir sabit ayak.
HRP20050281A2 (en) Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
HN2003000273A (es) Derivados heterociclicos
FI20020798A0 (fi) Venyke lahkeen pitelemiseksi